Observations
from the R&D Phase
The migration from capsule to liquid sachet format revealed structural differences between solid and aqueous systems. Ingredients that are stable and inert in encapsulated form require new compatibility validation when introduced into a liquid environment.
Dissolution behaviour becomes a primary performance indicator. Sensory parameters move from secondary consideration to central formulation constraint. Visual presentation becomes part of functional quality.
The R&D phase demonstrated that dosage format migration is not a linear adaptation process. It is a comprehensive reformulation workflow requiring laboratory iteration, sensory balancing and practical usability validation.
Further scale-up considerations, including microbiological stability and industrial homogenization parameters, will be addressed in subsequent development stages.